ANI Pharmaceuticals amends 2022 stock incentive plan effective May 21, 2026
ANI Pharmaceuticals restated its 2022 Stock Incentive Plan for the third time, updating equity compensation terms and definitions. The amendment affects employee incentive structures and equity participation mechanisms for the company's workforce.
View filing at SEC.gov →